Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

Lalitha L. Menon; Beatrice Chin; Muhammad A. Khattak

doi:10.1111/imj.14131

Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

Lalitha L. Menon, Beatrice Chin, Muhammad A. Khattak

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1542-1543
Number of pages	2
Journal	Internal Medicine Journal
Volume	48
Issue number	12
DOIs	https://doi.org/10.1111/imj.14131
Publication status	Published - 1 Dec 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/imj.14131

Cite this

@article{d7c5cbdded8043ecb39db3a1d99e959a,

title = "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)",

author = "Menon, {Lalitha L.} and Beatrice Chin and Khattak, {Muhammad A.}",

year = "2018",

month = dec,

day = "1",

doi = "10.1111/imj.14131",

language = "English",

volume = "48",

pages = "1542--1543",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley & Sons",

number = "12",

}

TY - JOUR

T1 - Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

AU - Menon, Lalitha L.

AU - Chin, Beatrice

AU - Khattak, Muhammad A.

PY - 2018/12/1

Y1 - 2018/12/1

UR - http://www.scopus.com/inward/record.url?scp=85057739247&partnerID=8YFLogxK

U2 - 10.1111/imj.14131

DO - 10.1111/imj.14131

M3 - Letter

C2 - 30517998

AN - SCOPUS:85057739247

SN - 1444-0903

VL - 48

SP - 1542

EP - 1543

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 12

ER -

Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

UN SDGs

Access to Document

Other files and links

Cite this